(E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU)
- PMID: 15389733
- DOI: 10.1002/med.20011
(E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU)
Abstract
(E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU, Brivudin, Zostex, Zerpex, Zonavir), now more than 20 years after its discovery, still stands out as a highly potent and selective inhibitor of herpes simplex virus type 1 (HSV-1) and varicella-zoster virus (VZV) infections. It has been used in the topical treatment of herpetic keratitis and recurrent herpes labialis and the systemic (oral) treatment of herpes zoster (zona, shingles). The high selectivity of BVDU towards HSV-1 and VZV depends primarily on a specific phosphorylation of BVDU to its 5'-diphosphate (DP) by the virus-encoded thymidine kinase (TK). After further phosphorylation (by cellular enzymes), to the 5'-triphosphate (TP), the compound interferes as a competitive inhibitor/alternate substrate with the viral DNA polymerase. The specific phosphorylation by the HSV- and VZV-induced TK also explains the marked cytostatic activity of BVDU against tumor cells that have been transduced by the viral TK genes. This finding offers considerable potential in a combined gene therapy/chemotherapy approach for cancer. To the extent that BVDU or its analogues (i.e., BVaraU) are degraded (by thymidine phosphorylase) to (E)-5-(2-bromovinyl)uracil (BVU), they may potentiate the anticancer potency, as well as toxicity, of 5-fluorouracil. This ensues from the direct inactivating effect of BVU on dihydropyrimidine dehydrogenase, the enzyme that initiates the degradative pathway of 5-fluorouracil. The prime determinant in the unique behavior of BVDU is its (E)-5-(2-bromovinyl) substituent. Numerous BVDU analogues have been described that, when equipped with this particular pharmacophore, demonstrate an activity spectrum characteristic of BVDU, including selective anti-VZV activity.
2004 Wiley Periodicals, Inc.
Similar articles
-
Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster.Biochem Pharmacol. 2004 Dec 15;68(12):2301-15. doi: 10.1016/j.bcp.2004.07.039. Biochem Pharmacol. 2004. PMID: 15548377 Review.
-
Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase.Cancer Gene Ther. 2000 Feb;7(2):215-23. doi: 10.1038/sj.cgt.7700108. Cancer Gene Ther. 2000. PMID: 10770629
-
Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 thymidine kinase gene.Mol Pharmacol. 1985 Dec;28(6):581-7. Mol Pharmacol. 1985. PMID: 3001499
-
Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.Mol Pharmacol. 1987 Sep;32(3):410-6. Mol Pharmacol. 1987. PMID: 2823092
-
The development of BVDU: An odyssey.Antivir Chem Chemother. 2023 Jan-Dec;31:20402066231152971. doi: 10.1177/20402066231152971. Antivir Chem Chemother. 2023. PMID: 36710501 Free PMC article. Review.
Cited by
-
Prodrug Strategies for the Development of β-l-5-((E)-2-Bromovinyl)-1-((2S,4S)-2-(hydroxymethyl)-1,3-(dioxolane-4-yl))uracil (l-BHDU) against Varicella Zoster Virus (VZV).J Med Chem. 2023 May 25;66(10):7038-7053. doi: 10.1021/acs.jmedchem.3c00545. Epub 2023 May 4. J Med Chem. 2023. PMID: 37140467 Free PMC article.
-
Neural Progenitor Cells Expressing Herpes Simplex Virus-Thymidine Kinase for Ablation Have Differential Chemosensitivity to Brivudine and Ganciclovir.Front Cell Neurosci. 2021 Dec 6;15:638021. doi: 10.3389/fncel.2021.638021. eCollection 2021. Front Cell Neurosci. 2021. PMID: 34938162 Free PMC article.
-
Novel strategies to prevent the development of multidrug resistance (MDR) in cancer.Oncotarget. 2017 Jul 12;8(48):84559-84571. doi: 10.18632/oncotarget.19187. eCollection 2017 Oct 13. Oncotarget. 2017. PMID: 29137448 Free PMC article. Review.
-
Distribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymerase.Nucleic Acids Res. 2016 Nov 16;44(20):9530-9554. doi: 10.1093/nar/gkw875. Epub 2016 Sep 29. Nucleic Acids Res. 2016. PMID: 27694307 Free PMC article. Review.
-
2-(2,4-Dioxy-1,2,3,4-Tetrahydropyrimidin-1-yl)-N-(4-Phenoxyphenyl)-Acetamides as a Novel Class of Cytomegalovirus Replication Inhibitors.Acta Naturae. 2015 Oct-Dec;7(4):142-5. Acta Naturae. 2015. PMID: 26798502 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources